These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 31343064)

  • 1. The Health and Economic Burdens of Lymphatic Filariasis Prior to Mass Drug Administration Programs.
    Mathew CG; Bettis AA; Chu BK; English M; Ottesen EA; Bradley MH; Turner HC
    Clin Infect Dis; 2020 Jun; 70(12):2561-2567. PubMed ID: 31343064
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The health and economic benefits of the global programme to eliminate lymphatic filariasis (2000-2014).
    Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Ottesen EA; Bradley MH
    Infect Dis Poverty; 2016 May; 5(1):54. PubMed ID: 27388873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A refined and updated health impact assessment of the Global Programme to Eliminate Lymphatic Filariasis (2000-2020).
    Turner HC; Ottesen EA; Bradley MH
    Parasit Vectors; 2022 May; 15(1):181. PubMed ID: 35643508
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The economic benefits resulting from the first 8 years of the Global Programme to Eliminate Lymphatic Filariasis (2000-2007).
    Chu BK; Hooper PJ; Bradley MH; McFarland DA; Ottesen EA
    PLoS Negl Trop Dis; 2010 Jun; 4(6):e708. PubMed ID: 20532228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health economic analyses of the Global Programme to Eliminate Lymphatic Filariasis.
    Turner HC
    Int Health; 2020 Dec; 13(Suppl 1):S71-S74. PubMed ID: 33349885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Elimination of lymphatic filariasis as a public health problem in Malawi.
    Chiphwanya J; Mkwanda S; Kabuluzi S; Mzilahowa T; Ngwira B; Matipula DE; Chaponda L; Ndhlova P; Katchika P; Mahebere Chirambo C; Moses P; Kumala J; Chiumia M; Barrett C; Betts H; Fahy J; Rebollo Polo M; Reimer L; Stanton MC; Thomas B; Freer S; Molyneux DH; Bockarie MJ; Mackenzie CD; Taylor MJ; Martindale S; Kelly-Hope LA
    PLoS Negl Trop Dis; 2024 Feb; 18(2):e0011957. PubMed ID: 38363794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. How much will it cost to eradicate lymphatic filariasis? An analysis of the financial and economic costs of intensified efforts against lymphatic filariasis.
    Kastner RJ; Sicuri E; Stone CM; Matwale G; Onapa A; Tediosi F
    PLoS Negl Trop Dis; 2017 Sep; 11(9):e0005934. PubMed ID: 28949987
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Assessing progress in reducing the at-risk population after 13 years of the global programme to eliminate lymphatic filariasis.
    Hooper PJ; Chu BK; Mikhailov A; Ottesen EA; Bradley M
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3333. PubMed ID: 25411843
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The global programme to eliminate lymphatic filariasis: health impact after 8 years.
    Ottesen EA; Hooper PJ; Bradley M; Biswas G
    PLoS Negl Trop Dis; 2008 Oct; 2(10):e317. PubMed ID: 18841205
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progress and impact of 13 years of the global programme to eliminate lymphatic filariasis on reducing the burden of filarial disease.
    Ramaiah KD; Ottesen EA
    PLoS Negl Trop Dis; 2014 Nov; 8(11):e3319. PubMed ID: 25412180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How Thailand eliminated lymphatic filariasis as a public health problem.
    Rojanapanus S; Toothong T; Boondej P; Thammapalo S; Khuanyoung N; Santabutr W; Prempree P; Gopinath D; Ramaiah KD
    Infect Dis Poverty; 2019 May; 8(1):38. PubMed ID: 31130143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National mass drug administration costs for lymphatic filariasis elimination.
    Goldman AS; Guisinger VH; Aikins M; Amarillo ML; Belizario VY; Garshong B; Gyapong J; Kabali C; Kamal HA; Kanjilal S; Kyelem D; Lizardo J; Malecela M; Mubyazi G; Nitièma PA; Ramzy RM; Streit TG; Wallace A; Brady MA; Rheingans R; Ottesen EA; Haddix AC
    PLoS Negl Trop Dis; 2007 Oct; 1(1):e67. PubMed ID: 17989784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modelling the health impact and cost-effectiveness of lymphatic filariasis eradication under varying levels of mass drug administration scale-up and geographic coverage.
    Stone CM; Kastner R; Steinmann P; Chitnis N; Tanner M; Tediosi F
    BMJ Glob Health; 2016; 1(1):e000021. PubMed ID: 28588916
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A game-theoretic model of lymphatic filariasis prevention.
    Rychtář J; Taylor D
    PLoS Negl Trop Dis; 2022 Sep; 16(9):e0010765. PubMed ID: 36137005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is mass drug administration against lymphatic filariasis required in urban settings? The experience in Kano, Nigeria.
    Pam DD; de Souza DK; D'Souza S; Opoku M; Sanda S; Nazaradden I; Anagbogu IN; Okoronkwo C; Davies E; Elhassan E; Molyneux DH; Bockarie MJ; Koudou BG
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0006004. PubMed ID: 29020042
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Information technology in morbidity management of human lymphatic filariasis-A promising tool in global programme for elimination of lymphatic filariasis.
    Devi RR; Raju V
    J Vector Borne Dis; 2018; 55(1):20-25. PubMed ID: 29916444
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolution of the monitoring and evaluation strategies to support the World Health Organization's Global Programme to Eliminate Lymphatic Filariasis.
    Lammie PJ; Gass KM; King J; Deming MS; Addiss DG; Biswas G; Ottesen EA; Henderson R
    Int Health; 2020 Dec; 13(Suppl 1):S65-S70. PubMed ID: 33349883
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investment Success in Public Health: An Analysis of the Cost-Effectiveness and Cost-Benefit of the Global Programme to Eliminate Lymphatic Filariasis.
    Turner HC; Bettis AA; Chu BK; McFarland DA; Hooper PJ; Mante SD; Fitzpatrick C; Bradley MH
    Clin Infect Dis; 2017 Mar; 64(6):728-735. PubMed ID: 27956460
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress and impact of 20 years of a lymphatic filariasis elimination programme in South-East Asia.
    Kapa DR; Mohamed AJ
    Int Health; 2020 Dec; 13(Suppl 1):S17-S21. PubMed ID: 33349881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lymphatic Filariasis: A Systematic Review on Morbidity and Its Repercussions in Countries in the Americas.
    Medeiros ZM; Vieira AVB; Xavier AT; Bezerra GSN; Lopes MFC; Bonfim CV; Aguiar-Santos AM
    Int J Environ Res Public Health; 2021 Dec; 19(1):. PubMed ID: 35010576
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.